About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Report Type
Organization
Disposition
Year
Month
Found 72611 record(s)
Req # A-2019-000403
Letters from Health Canada to all applicant companies regarding any abbreviated new drug submissions (ANDSs) made since October 1, 2019 for Azacitadine.Organization: Health Canada
September 2020
Req # A-2019-000762
All material pertaining to authorizing/approving, the re-organization of the Policy and Regulatory Strategies Directorate of the Regulatory Operations and Enforcement Branch that took place beginning in approximately March 2019 up to 19 August 2019.Organization: Health Canada
September 2020
Req # A-2019-000772
Copies of all Health Canada approved product labelling for Combogesic (Drug Identification Number 02488280), including labelling materials filed and approved in both text and mock-up format. All correspondence between AFT Pharmaceuticals Limited and…Organization: Health Canada
September 2020
Req # A-2019-001221
The complete list of authorised research licence under the Cannabis Act as of 09 Oct 2019. Including any research licence authorised as a subclass at a single site.Organization: Health Canada
September 2020
Req # A-2020-000439
Adverse Reaction Report (AER) for botulinum toxin type A. Report number: E2B_03075806.Organization: Health Canada
September 2020
Req # A-2019-001393
All records prepared for the Minister or the Deputy Minister of Health Canada, related to the discovery and treatment of bedbugs, in federal buildings in the Ottawa-Gatineau area from March 31 2019 to October 31 2019.Organization: Health Canada
September 2020
Req # A-2020-000059
In relation to the Non-Insured Health Benefits Program (the “NIHB”), all final letters, memoranda, memoranda to Cabinet, briefing notes, strategic plans, data/analyses, reports/evaluations, opinions or agreements (including funding agreements),Organization: Health Canada
September 2020
Req # A-2020-000297
All complaints from members of the public relating to Ranitidine products listed in the Health Canada public advisories dated September 13, 2019 and September 25, 2019. Original forms/reports only from September 1, 2014 to September 30, 2019.Organization: Health Canada
September 2020
Req # A-2020-000392
All adverse reaction reports for Atipamezole as well as the finalized copy of the investigator’s brochure for Atipamezole.Organization: Health Canada
September 2020
Req # A-2020-000493
The photography service contract for work meant to carried out between or on the following dates, final values, date of work, description, and location : 2019-07-05 to 2020-02-28, $9,900.00, July- Dec, 2019, Photography to support the new Healthy…Organization: Health Canada
September 2020